![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/18/2900405/0/en/Cerevance-Presents-at-The-Federation-of-European-Neuroscience-Societies-FENS-Forum-2024.html
https://www.globenewswire.com/news-release/2024/05/20/2884821/0/en/Cerevance-to-Participate-in-Precision-Neurotherapeutics-Panel-During-the-2024-BIO-International-Convention.html
https://www.globenewswire.com/news-release/2024/05/09/2878709/0/en/Cerevance-Presents-at-IAPRD-XXIX-World-Congress-on-Parkinson-s-Disease-and-Related-Disorders.html
https://www.globenewswire.com/news-release/2024/05/02/2874195/0/en/Cerevance-Achieves-First-Milestone-in-Research-Collaboration-with-Merck.html
https://www.globenewswire.com/news-release/2024/04/29/2871229/0/en/Cerevance-to-Participate-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/04/25/2869554/0/en/Cerevance-Adds-47-Million-in-Series-B-1-Extension-to-Advance-Robust-Clinical-Pipeline.html
https://www.globenewswire.com/news-release/2024/04/22/2866863/0/en/Cerevance-Publishes-CVN293-in-ACS-Medicinal-Chemistry-Letters.html
https://www.globenewswire.com/news-release/2024/04/17/2864532/0/en/Cerevance-Presents-at-35th-Symposium-on-Medicinal-Chemistry-in-Eastern-England.html
https://www.globenewswire.com/news-release/2024/04/02/2855950/0/en/Cerevance-to-Participate-at-the-23rd-Annual-Needham-Virtual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/03/13/2845419/0/en/Cerevance-Announces-Presentation-at-Alzheimer-s-Research-UK-Conference.html